Aspalathus linearis (Rooibos) Targets Adipocytes and Obesity-Associated Inflammation
暂无分享,去创建一个
A. Rossary | Caroline Vachias | E. Filaire | D. Fraisse | J. Berthon | L. Delort | C. Auxenfans | C. Decombat | M. Diab‐Assaf | Rawan Nehme | F. Caldefie-Chézet | F. Sénéjoux | Amandine Rousset | Arthur Chervet | Lucie Longechamp | Rebecca Boutin | Jean-Baptiste Guyon | A. Rousset | Caroline Decombat | A. Chervet | L. Longechamp
[1] Caroline Vachias,et al. A bicellular fluorescent ductal carcinoma in situ (DCIS)-like tumoroid to study the progression of carcinoma: practical approaches and optimization. , 2023, Biomaterials science.
[2] A. Kappo,et al. In vitro and in vivo hepatotoxicity study of Afriplex™ GRT through an inflammatory response , 2022, Toxicology reports.
[3] H. Assi,et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021 , 2022, International journal of molecular sciences.
[4] C. Muller,et al. New Insights into the Efficacy of Aspalathin and Other Related Phytochemicals in Type 2 Diabetes—A Review , 2021, International journal of molecular sciences.
[5] G. Guyatt,et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials , 2021, The Lancet.
[6] D. Ryan. Drugs for Treating Obesity. , 2021, Handbook of experimental pharmacology.
[7] Naeem Sheik Abdul,et al. Rooibos, a supportive role to play during the COVID-19 pandemic? , 2021, Journal of Functional Foods.
[8] Wadii Boulila,et al. A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity , 2021, Comput. Biol. Medicine.
[9] C. Calkhoven,et al. Obesity and its impact on COVID-19 , 2021, Journal of Molecular Medicine.
[10] E. Kalkhoven,et al. PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action , 2021, Frontiers in Endocrinology.
[11] T. Pers,et al. Hypothalamic hormone-sensitive lipase regulates appetite and energy homeostasis , 2021, Molecular Metabolism.
[12] S. Y. Lee,et al. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? , 2021, Current Obesity Reports.
[13] D. Langin,et al. Hormone-sensitive lipase: sixty years later. , 2020, Progress in lipid research.
[14] Tatsuo Kawai,et al. Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity. , 2020, American journal of physiology. Cell physiology.
[15] J. Eilers,et al. Multinucleated Giant Cells in Adipose Tissue Are Specialized in Adipocyte Degradation , 2020, Diabetes.
[16] A. Capasso,et al. Obesity: the New Global Epidemic. Pharmacological Treatment, Opportunities and Limits for Personalized Therapy. , 2020, Endocrine, metabolic & immune disorders drug targets.
[17] K. Zorena,et al. Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications , 2020, International journal of molecular sciences.
[18] D. Mcclements,et al. Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of an important nutraceutical , 2020, Critical reviews in food science and nutrition.
[19] Michael E. Hall,et al. Obesity, Hypertension, and Cardiac Dysfunction , 2020, Circulation research.
[20] F. Caldefie‐Chézet,et al. In Vitro Anti-Inflammatory and Immunomodulatory Activities of an Extract from the Roots of Bupleurum rotundifolium , 2019, Medicines.
[21] G. Paragh,et al. The Impact of Obesity on the Cardiovascular System , 2018, Journal of diabetes research.
[22] G. Frühbeck,et al. Adipokine dysregulation and adipose tissue inflammation in human obesity , 2018, European journal of clinical investigation.
[23] R. Judd,et al. Adiponectin Regulation and Function. , 2018, Comprehensive Physiology.
[24] Arielle Rowe,et al. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery , 2018, International journal of molecular sciences.
[25] J. Ankrum,et al. Scaffold-free generation of uniform adipose spheroids for metabolism research and drug discovery , 2018, Scientific Reports.
[26] C. Apovian,et al. Updates on obesity pharmacotherapy , 2018, Annals of the New York Academy of Sciences.
[27] Neil Miller,et al. Minimising variation in aspalathin content of aqueous green rooibos extract: optimising extraction and identifying critical material attributes. , 2017, Journal of the science of food and agriculture.
[28] C. Apovian. Obesity: definition, comorbidities, causes, and burden. , 2016, The American journal of managed care.
[29] P. Scherer,et al. Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. , 2016, Cell metabolism.
[30] T. Sen,et al. Medicinal plants, human health and biodiversity: a broad review. , 2014, Advances in biochemical engineering/biotechnology.
[31] P. López-Jaramillo,et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes , 2014, Hormone molecular biology and clinical investigation.
[32] C. Pheiffer,et al. Effects of fermented rooibos (Aspalathus linearis) on adipocyte differentiation. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[33] Y. Miura,et al. Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice , 2013, European Journal of Nutrition.
[34] A. Hahn,et al. Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations. , 2011, Food chemistry.
[35] I. Iswaldi,et al. Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[36] J. Sprent,et al. African legumes: a vital but under-utilized resource. , 2010, Journal of experimental botany.
[37] G. Williamson,et al. The C-glycosyl flavonoid, aspalathin, is absorbed, methylated and glucuronidated intact in humans. , 2009, Molecular nutrition & food research.
[38] A. Stalmach,et al. Bioavailability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas. , 2009, Journal of agricultural and food chemistry.
[39] M. Huang,et al. Transport of aspalathin, a Rooibos tea flavonoid, across the skin and intestinal epithelium , 2008, Phytotherapy research : PTR.
[40] B. Conway,et al. Obesity as a disease: no lightweight matter , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[41] P. Puigserver,et al. Transcriptional regulation of adipogenesis. , 2000, Genes & development.
[42] L. Igel,et al. Obesity Pharmacotherapy. , 2018, The Medical clinics of North America.
[43] LSU Digital Commons LSU Digital Commons Adipogenesis Adipogenesis , 2022 .